Use of rifampin for treatment of disseminated tuberculosis in a patient with primary myelofibrosis on ruxolitinib

Cytomegalovirus Retinitis in a Patient Who Received Ruxolitinib

(2016) Joanna von Hofsten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ruxolitinib-associated tuberculosis: a case of successful ruxolitinib rechallenge

(2014) Francesca Palandri et al.   ANNALS OF HEMATOLOGY

Disseminated tuberculosis associated with ruxolitinib

(2014) R K Hopman et al.   LEUKEMIA

Pulmonary tuberculosis reactivation following ruxolitinib treatment in a patient with primary myelofibrosis

(2014) Yen-Hao Chen et al.   LEUKEMIA & LYMPHOMA

JAKs and STATs in Immunity, Immunodeficiency, and Cancer

(2013) John J. O'Shea et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Pharmacokinetics, Pharmacodynamics, and Safety of Orally Dosed INCB018424 Phosphate in Healthy Volunteers

(2011) Jack G. Shi et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The Effect of CYP3A4 Inhibition or Induction on the Pharmacokinetics and Pharmacodynamics of Orally Administered Ruxolitinib (INCB018424 Phosphate) in Healthy Volunteers

(2011) Jack G. Shi et al.   JOURNAL OF CLINICAL PHARMACOLOGY